Artículos por temáticas
En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.
Tema
Trastornos del movimiento
116 ARTíCULOS , VIENDO DEL 1 AL 15
Coding for the use of botulinum toxin for movement disorders.
Brashear A, Bushong L.
Continuum (Minneap Minn). 2013 Oct;19(5 Movement Disorders):1406-15. doi: 10.1212/01.CON.0000436164.71565.c5. No abstract available.
0
0
0
Improving MRT image quality in patients with movement disorders.
Schültke E, Nanko N, Pinsker M, Katzev M, Sebastian A, Feige B, Nikkhah G.
Acta Neurochir Suppl. 2013;117:13-7. doi: 10.1007/978-3-7091-1482-7_3.
0
0
0
Autoantibody-associated movement disorders.
Mohammad SS, Ramanathan S, Brilot F, Dale RC.
Neuropediatrics. 2013 Dec;44(6):336-45. doi: 10.1055/s-0033-1358603. Review.
0
0
0
Movement disorders in 2012: Advancing research towards novel therapeutic approaches.
McFarland NR, Okun MS.
Nat Rev Neurol. 2013 Feb;9(2):70-1. doi: 10.1038/nrneurol.2012.265. Review.
0
0
0
[Depression associated with movement disorders].
Mao CJ, Chen JP, Hu WD, Liu CF.
Zhonghua Yi Xue Za Zhi. 2013 Jan 1;93(1):26-9. Chinese.
0
0
0
Continuation of long-term care for cervical dystonia at an academic movement disorders clinic.
Gill CE, Manus ND, Pelster MW, Cook JA, Title W, Molinari AL, Charles D.
Toxins (Basel). 2013 Apr 23;5(4):776-83. doi: 10.3390/toxins5040776.
0
0
0
Deep brain stimulation for Parkinson's disease and other movement disorders.
Kalia SK, Sankar T, Lozano AM.
Curr Opin Neurol. 2013 Aug;26(4):374-80. doi: 10.1097/WCO.0b013e3283632d08. Review.
0
0
0
Drug-induced movement disorders in children at paediatric emergency department: 'dystonia'.
Derinoz O, Caglar AA.
Emerg Med J. 2013 Feb;30(2):130-3. doi: 10.1136/emermed-2011-200691.
0
0
0
Kiesmann M, Chanson JB, Godet J, Vogel T, Schweiger L, Chayer S, Kaltenbach G.
J Neurol. 2013 Oct;260(10):2569-79. doi: 10.1007/s00415-013-7018-8.
0
0
0
Acute complications of movement disorders surgery: effects of age and comorbidities.
Rughani AI, Hodaie M, Lozano AM.
Mov Disord. 2013 Oct;28(12):1661-7. doi: 10.1002/mds.25610.
0
0
0
Simpson BS, Clarke CE.
Parkinsonism Relat Disord. 2013 Apr;19(4):461-2. doi: 10.1016/j.parkreldis.2012.09.001. No abstract available.
0
0
0
Complementary therapies in hemifacial spasm and comparison with other movement disorders.
Peeraully T, Hameed S, Cheong PT, Pavanni R, Hussein K, Fook-Chong SM, Tan EK.
Int J Clin Pract. 2013 Aug;67(8):801-6. doi: 10.1111/ijcp.12151. Review.
0
0
0
Movement disorders: Indian scenario: a clinico-genetic review.
Das SK, Ghosh B, Das G, Biswas A, Ray J.
Neurol India. 2013 Sep-Oct;61(5):457-66. doi: 10.4103/0028-3886.121908. Review.
0
0
0
Hallett M, Albanese A, Dressler D, Segal KR, Simpson DM, Truong D, Jankovic J.
Toxicon. 2013 Jun 1;67:94-114. doi: 10.1016/j.toxicon.2012.12.004. Review.
0
0
0
[Role of neurosurgical management in movement disorders other than Parkinson disease].
Taira T.
Rinsho Shinkeigaku. 2013;53(11):966-8. Review. Japanese.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
